Skip navigation
Skip navigation
You are using an outdated browser. Please upgrade your browser.

STERIS LIMITED
MEDIA RELEASE
14 APRIL 2005

STERIS TO UNVEIL ITS CONTRIBUTION TO FIGHTING THE MRSA SUPER BUG

Bold new scientific solutions for eradicating the deadly MRSA ‘super bug’ threat within hospitals and ambulances will be unveiled at a major summit on clean hospitals later this week.

The Clean Hospitals Summit, called by the Patients Association to find ways to solve the hospital super bug problem, will hear comprehensive evidence of how a technology which is standard in the food, medicines and research industries could be applied to healthcare environments to ensure patient areas are infection free.

STERIS, a worldwide leader in decontamination and infection prevention, will host a special seminar at the Summit to look at the work it has been conducting with ambulance services. Trials conducted with multiple ambulance trusts demonstrate a high level of environmental contamination within the patient and paramedic areas of emergency vehicles. These trails additionally demonstrated that current and traditional methods for cleaning emergency vehicle interiors have little effect in reducing contamination levels.

Following the use of STERIS’s proprietary Vaporized Hydrogen Peroxide (VHP®) fumigation technology, trial data showed that ambulances could be fully decontaminated within two hours. Further trials of the VHP technology have now taken place with other ambulance service trusts across the United Kingdom.

Reporting on parallel research using STERIS’s technology, a speaker from a leading UK hospital will discuss how STERIS’s VHP technology assisted the hospital in decontaminating a ward following a period of persistent MRSA contamination.

The Department of Health has approved the use of VHP following a special Rapid Review Panel assessment gave the technology the green light to fight infection in hospitals.

Les Vinney, Chief Executive Officer of STERIS Corporation will tell the summit:

“Hospital acquired infections are not only a general public health issue but also a significant economic issue in the world. The cost in the United Kingdom alone is estimated at 1 billion pounds sterling annually. “

“In ambulance trials, we found the inside of ambulances contaminated with MRSA even after traditional decontamination methods had been used. Using STERIS’s VHP technology we were able to decontaminate the ambulance within a few hours with full validation and without damaging the surfaces and sensitive electronic equipment inside the vehicle.”

“Other industries requiring the highest levels of contamination control have replaced or enhanced their processes by moving from the more basic wipe down cleaning protocols and chemistries such as detergents and disinfectants to the increased use of VHP.”

ENDS


Notes to Editors:

1. For media calls only please contact either Nick Sutcliffe (+44 7730 898 165) or Jonathan Simpson (+44 7968 537 320).

2. The Clean Hospital Summit will take place between on Thursday 14 April and Friday 15 April 2005 at the London Hilton Metropole. STERIS is one of the primary sponsors of the Summit.

3. Les Vinney, Chief Executive Officer of the STERIS Corporation, will give a key note speech to the conference on the morning of Thursday 14th April. He will be available for interview throughout the day on the 14th. The full text of his speech is available on request.

4. STERIS will be giving a live demonstration of their VHP technology on an ambulance at the entrance of the London Hilton Metropole on Thursday and Friday.

5. The mission of STERIS Corporation is to provide a healthier today and safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. Additional information about STERIS can be found on the Company's Website at www.steris.com.

This press release was distributed by ResponseSource Press Release Wire on behalf of APCO UK in the following categories: Health, for more information visit https://pressreleasewire.responsesource.com/about.